Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 22

Sort by

Sort Order Select

Journal Articles

Rapid normalization of platelet counts in patients with refractory thrombocytopenia associated with systemic lupus erythematosus (SLE) following treatment with allogeneic dual-target CD19/BCMA CAR T-cell therapy (QT-019B)

Blood (2025) 146 (Supplement 1): 3031.

https://doi.org/10.1182/blood-2025-3031

Published: 2025

Journal Articles

Detection of NPM1 mutation in Acute Myeloid Leukemia by multiple droplet digital PCR and its clinical application value

keyi chen, Xinhai Deng, yixuan li, yueru luo, Sanyun Wu, Fuling Zhou, li he

Blood (2025) 146 (Supplement 1): 2571.

https://doi.org/10.1182/blood-2025-2571

Published: 2025

Journal Articles

Monitoring MRD and clinical utility of DNMT3A R882 in AML by multiplex droplet digital PCR

Xinhai Deng, keyi chen, yixuan li, yueru luo, Fuling Zhou, li he, Sanyun Wu

Blood (2025) 146 (Supplement 1): 7867.

https://doi.org/10.1182/blood-2025-7867

Published: 2025

Journal Articles

Analysis of non-driver mutation characteristics in primary myelofibrosis

yueru luo, yixuan li, Xinhai Deng, keyi chen, Sanyun Wu, Xue Lan Zuo, Fuling Zhou, li he

Blood (2025) 146 (Supplement 1): 7329.

https://doi.org/10.1182/blood-2025-7329

Published: 2025

Journal Articles

Allogeneic dual-target CD19/BCMA CAR T-cell therapy (QT-019B) for refractory autoimmune hemolytic anemia

Blood (2025) 146 (Supplement 1): 5922.

https://doi.org/10.1182/blood-2025-5922

Published: 2025

Journal Articles

Chimeric Antigen Receptor T Cell Therapy in the Relapsed or Refractory Multiple Myeloma with Extramedullary Disease--a Single Institution Observation in China

Baiyan Wang, MD PhD, Jie Liu, MD, Wan-Hong Zhao, MD PhD, Yin-Xia Chen, MD, Xing-Mei Cao, MD, Yun Yang, MD, Yi-Lin Zhang, MD, Fang-Xia Wang, MD PhD, Peng-Yu Zhang, MD PhD, Bo Lei, MD, Liu-Fang Gu, MD PhD, Jian-Li Wang, MD PhD, Frank Xiao-Hu Fan, MD PhD, Wang-Gang Zhang, MD PhD, Ai-Li He, MD PhD

Blood (2020) 136 (Supplement 1): 6.

https://doi.org/10.1182/blood-2020-140243

Published: 2020

Journal Articles

Long-Term Follow-up of a Phase 1, First-in-Human Open-Label Study of LCAR-B38M, a Structurally Differentiated Chimeric Antigen Receptor T (CAR-T) Cell Therapy Targeting B-Cell Maturation Antigen (BCMA), in Patients (pts) with Relapsed/Refractory Multiple Myeloma (RRMM)

Blood (2019) 134 (Supplement_1): 579.

https://doi.org/10.1182/blood-2019-124953

Published: 2019

Journal Articles

Efficacy and Adverse Reactions of Gemcitabine Combined with Cyclophosphamide, Vinblastine and Prednisone Hydrogenation Regiments in Relapse and/or Refractory Non-Hodgkin's Lymphoma

Baiyan Wang, MD PhD, Jie Liu, MD, Yin-Xia Chen, MD, Xing-Mei Cao, MD, Wan-Hong Zhao, MD PhD, Jian-Li Wang, MD PhD, Xiao-Rong Ma, MD PhD, Yun Yang, MD, Peng-Yu Zhang, MD PhD, Fang-Xia Wang, MD PhD, Liu-Fang Gu, MD PhD, Bo Lei, MD, Jin Wang, MD PhD, Ju Bai, PhD, Yi-Lin Zhang, MD, Yan Xu, Ai-Li He, MD PhD, Wang-Gang Zhang, MD PhD

Blood (2018) 132 (Supplement 1): 5393.

https://doi.org/10.1182/blood-2018-99-116600

Published: 2018

Journal Articles

Updated Analysis of a Phase 1, Open-Label Study of LCAR-B38M, a Chimeric Antigen Receptor T Cell Therapy Directed Against B-Cell Maturation Antigen, in Patients with Relapsed/Refractory Multiple Myeloma

Blood (2018) 132 (Supplement 1): 955.

https://doi.org/10.1182/blood-2018-99-110548

Published: 2018

Journal Articles

Cartilage oligomeric matrix protein is a natural inhibitor of thrombin

Ying Liang, Yi Fu, Ruomei Qi, Meili Wang, Nan Yang, Li He, Fang Yu, Jian Zhang, Cai-Hong Yun, Xian Wang, Junling Liu, Wei Kong

Blood (2015) 126 (7): 905–914.

https://doi.org/10.1182/blood-2015-01-621292

Published: 2015

Includes: Supplemental data

Journal Articles

Expression Of Cancer-Testis Antigen In Multiple Myeloma

Jingna Ji, Jr, Shangqin Liu, Sr., PHD, Li He, Chaoping Xu, Jr., Guiying Hu, Yicheng Zhang, Zi Ma, Sr., Jianying Huang

Blood (2013) 122 (21): 5341.

https://doi.org/10.1182/blood.V122.21.5341.5341

Published: 2013

Journal Articles

Baicalein Synergy Lenalidomide To Induce Apoptosis Of Myeloma Cell

Ruibo Zhang, Jr., Zi Ma, Sr., Shangqin Liu, Sr., PHD, Li He, Jr., Chaoping Xu, Jr., Guiying Hu, Jianying Huang, Yicheng Zhang

Blood (2013) 122 (21): 5328.

https://doi.org/10.1182/blood.V122.21.5328.5328

Published: 2013

Journal Articles

Baicalein Inhibites Multiple Myeloma Cells Proliferation and Migration by Interfering Wnt Signaling Pathway

Chaoping Xu, Jr., Shangqin Liu, Sr., Jianying Huang, Sr., Yicheng Zhang, Sr., Li He, Jr., Huili Cai, Jr., Ruibo Zhang, Jr., Jinna Ji, Jr., Dingxin Zhou, Jr., Zi Ma, Sr.

Blood (2012) 120 (21): 5019.

https://doi.org/10.1182/blood.V120.21.5019.5019

Published: 2012

Journal Articles

Induction of CRBN(Cereblon) mRNA Expression by Baicalein

Zi Ma, Sr., Rui bo Zhang, Li He, Chao ping Xu, Ding xin Zhou, Jing na Ji, Jianying Huang, Yicheng Zhang, Sr., Shang qin Liu, Sr.

Blood (2012) 120 (21): 5025.

https://doi.org/10.1182/blood.V120.21.5025.5025

Published: 2012

Journal Articles

Concomitant JAK2 V617F-Positive Polycythemia Vera and BCR-ABL -Positive Chronic Myelogenous Leukemia Treated with Ruxolitinib and Dasatinib.

Eric M. Knoche, MD, Daniel A.C. Fisher, PhD, Gregory Rippberger, Li He, MS, BS, Deborah M. Moore, Jonathan L. Klein, MD, Stephen T. Oh, MD, PhD

Blood (2012) 120 (21): 2832.

https://doi.org/10.1182/blood.V120.21.2832.2832

Published: 2012

Journal Articles

Hypoxia-inducible factor-1 drives annexin A2 system-mediated perivascular fibrin clearance in oxygen-induced retinopathy in mice

Bihui Huang, Arun B. Deora, Kai-Li He, Kang Chen, Guangzhi Sui, Andrew T. Jacovina, Dena Almeida, Peng Hong, Paul Burgman, Katherine A. Hajjar

Blood (2011) 118 (10): 2918–2929.

https://doi.org/10.1182/blood-2011-03-341214

Published: 2011

Includes: Supplemental data

Journal Articles

Vascular dermatan sulfate regulates the antithrombotic activity of heparin cofactor II

Li He, Tusar K. Giri, Cristina P. Vicente, Douglas M. Tollefsen

Blood (2008) 111 (8): 4118–4125.

https://doi.org/10.1182/blood-2007-12-127928

Published: 2008

Journal Articles

Accelerated atherogenesis and neointima formation in heparin cofactor II–deficient mice

Cristina P. Vicente, Li He, Douglas M. Tollefsen

Blood (2007) 110 (13): 4261–4267.

https://doi.org/10.1182/blood-2007-04-086611

Published: 2007

Journal Articles

Fusion proteins comprising annexin V and Kunitz protease inhibitors are highly potent thrombogenic site-directed anticoagulants

Hsiu-Hui Chen, Cristina P. Vicente, Li He, Douglas M. Tollefsen, Tze-Chein Wun

Blood (2005) 105 (10): 3902–3909.

https://doi.org/10.1182/blood-2004-11-4435

Published: 2005

Journal Articles

Antithrombotic activity of dermatan sulfate in heparin cofactor II-deficient mice

Cristina P. Vicente, Li He, Mauro S. G. Pavão, Douglas M. Tollefsen

Blood (2004) 104 (13): 3965–3970.

https://doi.org/10.1182/blood-2004-02-0598

Published: 2004

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Rapid normalization of platelet counts in patients with refractory thrombocytopenia associated with systemic lupus erythematosus (SLE) following treatment with allogeneic dual-target CD19/BCMA CAR T-cell therapy (QT-019B)

Detection of NPM1 mutation in Acute Myeloid Leukemia by multiple droplet digital PCR and its clinical application value

Monitoring MRD and clinical utility of DNMT3A R882 in AML by multiplex droplet digital PCR

Analysis of non-driver mutation characteristics in primary myelofibrosis

Allogeneic dual-target CD19/BCMA CAR T-cell therapy (QT-019B) for refractory autoimmune hemolytic anemia

Chimeric Antigen Receptor T Cell Therapy in the Relapsed or Refractory Multiple Myeloma with Extramedullary Disease--a Single Institution Observation in China

Long-Term Follow-up of a Phase 1, First-in-Human Open-Label Study of LCAR-B38M, a Structurally Differentiated Chimeric Antigen Receptor T (CAR-T) Cell Therapy Targeting B-Cell Maturation Antigen (BCMA), in Patients (pts) with Relapsed/Refractory Multiple Myeloma (RRMM)

Efficacy and Adverse Reactions of Gemcitabine Combined with Cyclophosphamide, Vinblastine and Prednisone Hydrogenation Regiments in Relapse and/or Refractory Non-Hodgkin's Lymphoma

Updated Analysis of a Phase 1, Open-Label Study of LCAR-B38M, a Chimeric Antigen Receptor T Cell Therapy Directed Against B-Cell Maturation Antigen, in Patients with Relapsed/Refractory Multiple Myeloma

Cartilage oligomeric matrix protein is a natural inhibitor of thrombin

Expression Of Cancer-Testis Antigen In Multiple Myeloma

Baicalein Synergy Lenalidomide To Induce Apoptosis Of Myeloma Cell

Baicalein Inhibites Multiple Myeloma Cells Proliferation and Migration by Interfering Wnt Signaling Pathway

Induction of CRBN(Cereblon) mRNA Expression by Baicalein

Concomitant JAK2 V617F-Positive Polycythemia Vera and BCR-ABL -Positive Chronic Myelogenous Leukemia Treated with Ruxolitinib and Dasatinib.

Hypoxia-inducible factor-1 drives annexin A2 system-mediated perivascular fibrin clearance in oxygen-induced retinopathy in mice

Vascular dermatan sulfate regulates the antithrombotic activity of heparin cofactor II

Accelerated atherogenesis and neointima formation in heparin cofactor II–deficient mice

Fusion proteins comprising annexin V and Kunitz protease inhibitors are highly potent thrombogenic site-directed anticoagulants

Antithrombotic activity of dermatan sulfate in heparin cofactor II-deficient mice

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only